111 – 120 of 393
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model.
(
- Contribution to journal › Article
-
Mark
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Serum but not Cerebrospinal Fluid levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 (IGFBP-3) are Increased in Alzheimer ́s Disease
2013) Endokrindagarna, 2013(
- Contribution to conference › Poster
- 2012
-
Mark
Differential Development of Glucose Intolerance and Pancreatic Islet Adaptation in Multiple Diet Induced Obesity Models
(
- Contribution to journal › Article
-
Mark
Vildagliptin Reduces Glucagon during Hyperglycemia and Sustains Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
(
- Contribution to journal › Article
-
Mark
Varning för okritisk användning av överviktskirurgi vid typ 2-diabetes.
(
- Contribution to journal › Article
-
Mark
DPP-4 inhibition and islet function
(
- Contribution to journal › Scientific review
-
Mark
The hyperstimulated beta-cell: prelude to diabetes?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
(
- Contribution to journal › Article
-
Mark
Synergism by individual macronutrients explains the marked early GLP-1 and islet hormone responses to mixed meal challenge in mice.
(
- Contribution to journal › Article